Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Glaucoma: Overview01:25

Glaucoma: Overview

1.4K
Glaucoma is an eye condition characterized by increased intraocular pressure that damages the retina and optic nerve, leading to irreversible blindness if left untreated. The human eye has various components, including the cornea, iris, pupil, lens, and optic nerve. Aqueous humor is secreted by the epithelium of the ciliary body in the posterior chamber and flows through the trabecular meshwork and canal of Schlemm, maintaining normal intraocular pressure. The trabecular meshwork and the canal...
1.4K
Open Angle Glaucoma: Treatment01:27

Open Angle Glaucoma: Treatment

996
In open-angle glaucoma, the iridocorneal angle remains open, but the trabecular meshwork becomes stiff, slowing down the outflow of aqueous humor. This causes a buildup of aqueous humor in the anterior chamber, leading to a sudden increase in intraocular pressure. The treatment for open-angle glaucoma focuses on reducing the elevated intraocular pressure by either decreasing the secretion of aqueous humor or increasing its outflow.
Drugs such as carbonic anhydrase inhibitors, α2- and...
996
Inhaled Medications01:23

Inhaled Medications

800
Inhaled medications are crucial for managing chronic obstructive pulmonary disease (COPD) and asthma. They are essential for effective treatment and control, ensuring optimal respiratory health and well-being. Inhaled medication delivers drugs directly to the lungs, providing a rapid onset of action and reducing systemic side effects compared to oral or injectable medications. Three primary types of inhalation devices are used to administer these medications: nebulizers, metered-dose inhalers...
800
Angle Closure Glaucoma: Treatment01:28

Angle Closure Glaucoma: Treatment

1.3K
Angle-closure glaucoma, or closed-angle glaucoma, is an eye condition where the iris bulges out and blocks the iridocorneal angle, resulting in a buildup of aqueous humor and increased intraocular pressure. Immediate medical attention is necessary due to the sudden onset of symptoms. The treatment for angle-closure glaucoma includes short-term and long-term approaches. Short-term treatment involves using eye drops like pilocarpine to lower intraocular pressure by increasing aqueous humor...
1.3K
Endocarditis III: Medical Management01:18

Endocarditis III: Medical Management

258
Infective endocarditis management involves a multifaceted approach encompassing infection prevention, lifestyle modifications, pharmacological therapy, and surgical management.Infection Prevention:Hand Hygiene: Thorough handwashing is crucial to prevent the spread of infection. Hand hygiene should be performed regularly, especially before and after using the restroom.Oral Hygiene: Good oral hygiene is essential. It includes brushing teeth immediately after waking up and before bed, flossing...
258
Myocarditis III: Medical Management01:14

Myocarditis III: Medical Management

218
Myocarditis: Comprehensive Medical ManagementMyocarditis, the heart muscle inflammation, requires a comprehensive medical management strategy that addresses the underlying cause, provides supportive care, manages symptoms, and reduces cardiac workload.Infections and Autoimmune CausesAdminister appropriate antimicrobial therapy when an infectious agent causes myocarditis. For instance, penicillin treats infections caused by Group A Streptococcus. In cases where autoimmune processes are...
218

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

New forays into measurement of ocular biomechanics.

Current opinion in ophthalmology·2024
Same author

Corneal biomechanical properties in hyperthyroidism and thyroid eye disease.

Saudi journal of ophthalmology : official journal of the Saudi Ophthalmological Society·2021
Same author

Effect of Anticoagulants and Surgeon-Related Factors on Short-term Outcomes of Laser Peripheral Iridotomy.

Ophthalmology. Glaucoma·2020
Same author

Outcomes of trabecular microbypass surgery: Comparison of resident trainees and attending surgeons.

Journal of cataract and refractive surgery·2019
Same author

Pneumotonometer Accuracy Using Manometric Measurements after Radial Keratotomy, Clear Corneal Incisions and Lamellar Dissection in Porcine Eyes.

Current eye research·2019
Same author

Philadelphia Telemedicine Glaucoma Detection and Follow-up Study: Intraocular Pressure Measurements Found in a Population at High Risk for Glaucoma.

Journal of glaucoma·2019

Related Experiment Video

Updated: Feb 1, 2026

Ultrasound Cyclo Plasty in Eyes with Glaucoma
05:05

Ultrasound Cyclo Plasty in Eyes with Glaucoma

Published on: January 26, 2018

12.7K

Glaucoma medications in pregnancy.

M Reza Razeghinejad1

  • 1Glaucoma Service, Wills Eye Hospital, Philadelphia, PA, USA.

Oman Journal of Ophthalmology
|December 4, 2018
PubMed
Summary

Managing glaucoma during pregnancy presents challenges due to potential medication risks for the fetus. Brimonidine is the only Category B drug, while others are Category C, necessitating careful patient-physician discussion.

Area of Science:

  • Ophthalmology
  • Pharmacology
  • Maternal-Fetal Medicine

Background:

  • Glaucoma management in childbearing-aged women is challenging.
  • Intraocular pressure may decrease during pregnancy, but treatment is often still required.
  • Antiglaucoma medications pose risks to both the mother and the developing fetus.

Purpose of the Study:

  • To review the safety and efficacy of glaucoma medications during pregnancy.
  • To highlight the limited evidence available for drug safety in pregnant glaucoma patients.
  • To emphasize the importance of shared decision-making in therapeutic choices.

Main Methods:

  • Review of existing literature on glaucoma medications in pregnancy.
  • Analysis of drug categorization (FDA categories) for commonly used antiglaucoma agents.
Keywords:
Alpha-2 agonistsbeta-blockerscarbonic anhydrase inhibitorsglaucomaglaucoma medicationspregnancyprostaglandins

More Related Videos

A Novel Use of Three-dimensional High-frequency Ultrasonography for Early Pregnancy Characterization in the Mouse
07:04

A Novel Use of Three-dimensional High-frequency Ultrasonography for Early Pregnancy Characterization in the Mouse

Published on: October 24, 2017

8.9K
Pregnancy and Nursing Management for Embryo-Transferred and Genetically Modified Rabbits
04:29

Pregnancy and Nursing Management for Embryo-Transferred and Genetically Modified Rabbits

Published on: December 13, 2024

1.3K

Related Experiment Videos

Last Updated: Feb 1, 2026

Ultrasound Cyclo Plasty in Eyes with Glaucoma
05:05

Ultrasound Cyclo Plasty in Eyes with Glaucoma

Published on: January 26, 2018

12.7K
A Novel Use of Three-dimensional High-frequency Ultrasonography for Early Pregnancy Characterization in the Mouse
07:04

A Novel Use of Three-dimensional High-frequency Ultrasonography for Early Pregnancy Characterization in the Mouse

Published on: October 24, 2017

8.9K
Pregnancy and Nursing Management for Embryo-Transferred and Genetically Modified Rabbits
04:29

Pregnancy and Nursing Management for Embryo-Transferred and Genetically Modified Rabbits

Published on: December 13, 2024

1.3K
  • Examination of evidence from case reports and animal studies.

    • Main Results:

    • Brimonidine is the only antiglaucoma medication in FDA Category B; others are Category C.
    • Limited human studies exist, with most evidence derived from case reports and animal studies.
    • While theoretical risks to the fetus exist, substantial clinical significance with routine dosages is not definitively established for topical agents.

    Conclusions:

    • No topical antiglaucoma agents have strong evidence of fetal safety based on human studies.
    • Management requires careful consideration of potential risks and benefits.
    • Informed patient involvement in therapeutic decisions is crucial due to study limitations.